Implant volume as a prognostic variable in brachytherapy decision-making for malignant gliomas stratified by the rtog recursive partitioning analysis
- 1 November 2001
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 51 (4), 963-968
- https://doi.org/10.1016/s0360-3016(01)01746-1
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomasInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Randomized study of brachytherapy in the initial management of patients with malignant astrocytomaInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Interstitial brachytherapy for malignant brain tumorsSeminars in Surgical Oncology, 1998
- Permanent Iodine-125 Implants in the Up-front Treatment of Malignant GliomasNeurosurgery, 1995
- Selection bias, survival, and brachytherapy for gliomaJournal of Neurosurgery, 1992
- Combined Radiotherapy of High-Grade Gliomas with Stereotactic Implanted Iodine-125 Seeds and Fractionated Low-Dose Rate Beam Irradiation: Preliminary ResultsPublished by Springer Science and Business Media LLC ,1992
- Permanent Iodine-125 Implant and External Beam Radiation Therapy for the Treatment of Malignant Brain TumorsStereotactic and Functional Neurosurgery, 1992
- External irradiation followed by an interstitial high activity iodine-125 implant “boost” in the initial treatment of malignant gliomas: NCOG study 6G-82-2 gliomas: NCOG study 6H-82-2International Journal of Radiation Oncology*Biology*Physics, 1991
- Results of Stereotactic Brachytherapy Used in the Initial Management of Patients With GlioblastomaJNCI Journal of the National Cancer Institute, 1990
- Interstitial Irradiation of Brain TumorsNeurosurgery, 1981